Ultrasound-mediated gene transfection in vitro: Effect of ultrasonic parameters on efficiency and cell viability

International Journal of Hyperthermia

Volumn 28, Issue 4, 2012, Pages 290-299

  Zhang, Yiwei ^a   Tachibana, Rie ^a   Okamoto, Akio ^a   Azuma, Takashi ^a   Sasaki, Akira ^a   Yoshinaka, Kiyoshi ^b   Tei, Yuichi ^a   Takagi, Shu ^a   Matsumoto, Yoichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Cell viability; Gene transfection; Microbubble; Ultrasound

Indexed keywords

PERFLUBUTANE; PLASMID DNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DEATH; CELL STRAIN 3T3; CELL VIABILITY; CONCENTRATION (PARAMETERS); DNA TRANSFECTION; EMBRYO; FIBROBLAST; IN VITRO GENE TRANSFER; IRRADIATION; MICROBUBBLE; MOUSE; NONHUMAN; RADIATION EXPOSURE; RADIOLOGICAL PARAMETERS; REPRODUCIBILITY; ULTRASOUND;

ANIMALS; CELL SURVIVAL; CONTRAST MEDIA; DNA; FERRIC COMPOUNDS; GREEN FLUORESCENT PROTEINS; IRON; MICE; MICROBUBBLES; NIH 3T3 CELLS; OXIDES; SOUND; TRANSFECTION; ULTRASONIC THERAPY;

EID: 84861520217     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2012.665568     Document Type: Article

References (45)

1. Friedmann T, Roblin R. Gene therapy for human genetic disease? Science 1972;175:949-955.
2. Friedmann T. Progress toward human gene therapy. Science 1989;244:1275-1281.
3. Mountain A. Gene therapy: The first decade. Tibtech 2000;18:119-128.
4. Verma IM, Weitzman MD. Gene therapy: Twenty-first century medicine. Annu Rev Biochem 2005;74:711-738.
5. Gardlík R, Pálffy R, Hodosy J, Lukács J, Turna J, Celec P. Vectors and delivery systems in gene therapy. Med Sci Monit 2005;11:110-121.
6. Robbins PD, Ghivizzani SC. Viral vector for gene therapy. Pharmacol Ther 1998;80:35-47.
7. Stone D, David A, Bolognani F, Lowenstein PR, Castro MG. Viral vectors for gene delivery and gene therapy within the endocrine system. J Endocrinol 2000;164:103-118.
8. Kootstra NA, Verma IM. Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol 2003;43:413-439.
9. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nature Rev Genet 2003;4:346-358.
10. Davidson BL, Breakefield XO. Viral vectors for gene delivery to the nervous system. Nature Rev Neurosci 2003;4:353-364.
11. Gao X, Kim KS, Liu D. Nonviral gene delivery: What we know and what is next. AAPS Journal 2007;9:E93-E104.
12. Davis ME. Non-viral gene delivery systems. Curr Opin Biotech 2002;13:128-131.
13. Wiethoff CM, Middaugh CR. Barriers to nonviral gene delivery. J Pharm Sci 2003;92:203-217.
14. Wells DJ. Gene therapy progress and prospects: Electroporation and other physical methods. Gene Ther 2004;11:1363-1369.
15. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009;109:259-302.
16. Seow Y, Wood MJ. Biological gene delivery vehicles: Beyond viral vectors. Mol Ther 2009;17:767-777.
17. Wells DJ. Electroporation and ultrasound enhanced non-viral gene delivery in vitro and in vivo. Cell Biol Toxicol 2010;26:21-28.
18. Newman CM, Lawrie A, Brisken AF, Cumberland DC. Ultrasound gene therapy: On the road from concept to reality. Echocardiography 2001;18:339-347.
19. Miller DL, Pislaru SV, Greenleaf JF. Sonoporation: Mechanical DNA delivery by ultrasonic cavitation. Som Cell and Mol Genet 2002;27:115-134.
20. Pitt WG, Husseini GA, Staples BJ. Ultrasonic drug delivery-A general review. Expert Opin Drug Deliv 2004;1:37-56.
21. ter Haar GR, Coussios CC. High intensity focused ultrasound: Past, present and future. Int J Hyperther. 2007; 23: 85-87.
22. ter Haar GR, Coussios CC. High intensity focused ultrasound: Physical principles and devices. Int J Hyperther 2007: 23; 89-104.
23. Coussios CC, Farny CH, ter Haar GR, Roy RA. Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focused ultrasound. Int J Hyperther 2007;23:105-120.
24. Kim HJ, Greenleaf JF, Kinnick RR, Bronk JT, Bolander ME. Ultrasound-mediated transfection of mammalian cells. Hum Gene Ther 1996;7:1339-1346.
25. Stride E, Saffari N. Microbubble ultrasound contrast agents: A review. Proc Inst Mech Eng H J 2003;217:429-447.
26. Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: Fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007;9:415-447.
27. Lawrie A, Brisken AF, Francis SE, Cumberland DC, Crossman DC, Newman CM. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 2000;7:2023-2027.
28. Toniyama Y, Tachibana K, Hiraoka K, Namba T, Yamasaka K, Hashiya N, et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002;105:1233-1239.
29. Christiansen JP, French BA, Klibanov AL, Kaul S, Lindner JR. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol 2003;29:1759-1767.
30. Mehier-Humbert S, Bettinger T, Yan F, Guy RH. Ultrasound-mediated gene delivery: Kinetics of plasmid internalization and gene expression. J Control Release 2005;104:203-211.
31. Feril LB, Ogawa R, Tachibana K, Kondo T. Optimized ultrasound-mediated gene transfection in cancer cells. Cancer Sci 2006;97:1111-1114.
32. Mehier-Humbert S, Yan F, Frinking P, Schneider M, Guy RH, Bettinger T. Ultrasound-mediated gene delivery: Influence of contrast agents on transfection. Bioconjugate Chem 2007;18:652-662.
33. O'Neill BE, Li KCP. Augmentation of targeted delivery with pulsed high intensity focused ultrasound. Int J Hyperther 2008;24:506-520.
34. Kobulnik J, Kuliszewski MA, Stewart DJ, Lindner JR, Leong-Poi H. Comparison of gene delivery techniques for therapeutic angiogenesis: Ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection. J Am Coll Cardiol 2009;54:1735-1742.
35. Phillips LC, Klibanov AL, Wamhoff BR, Hossack JA. Targeted gene transfection from microbubbles into vascular smooth muscle cells using focused, ultrasound-mediated delivery. Ultrasound Med Biol 2010;36:1470-1480.
36. Reslan L, Mestas JL, Herveau S, Béra JC, Dumontet C. Transfection of cells in suspension by ultrasound cavitation. J Control Release 2010;142:251-258.
37. Delalande A, Bouakaz A, Renault G, Tabareaue F, Kotopoulis S, Midoux P, et al. Ultrasound and microbub-ble-assisted gene delivery in Achilles tendons: Long lasting gene expression and restoration of fibromodulin KO pheno-type. J Control Release 2011;156:223-230.
38. Karshafian R, Bevan PD, Willams R, Samac S, Burns PN. Sonoporation by ultrasound-activated microbubble contrast agents: Effect of acoustic exposure parameters on cell membrane permeability and cell viability. Ultrasound Med Bio 2009;35:847-860.
39. Rahim A, Taylor SL, Bush NL, ter Haar GR, Bamber JC, Porter CD. Physical parameters affecting ultrasound/micro-bubble mediated gene delivery efficiency in vitro. Ultrasound Med Biol 2006;32:1269-1279.
40. Newman CM, Bettinger T. Gene therapy progress and prospects: Ultrasound for gene transfer. Gene Ther 2007;14:465-475.
41. Liang HD, Lu QL, Xue SA, Halliwell M, Kodama T, Cosgrove DO, et al. Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells. Ultrasound Med Biol 2004;30:1523-1529.
42. Chen SY, Shohet RV, Bekeredjian R, Frenkel P, Grayburn PA. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonu-cleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003;42:301-308.
43. Zarnitsyn VG, Prausnitz MR. Physical parameters influencing optimization of ultrasound-mediated DNA transfection. Ultrasound Med Biol 2004;30:527-538.
44. Wu JR, Ross JP, Chiu JF. Reparable sonoporation generated by microstreaming. J Acoust Soc Am 2002;111:1460-1464.
45. Zhou Y, Cui JM, Deng CX. Dynamics of sonoporation correlated with acoustic cavitation activities. Biophys J 2008;94:L51-L53.